AI, productivity, and digital capabilities: cross-country evidence from early adoption
Industrial and Corporate Change · 15.10.2026
DOI: 10.1093/icc/dtag043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Industrial and Corporate Change, online erschienen am 15.10.2026. Verfasst von Flavio Calvino und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This work analyses the early use of artificial intelligence (AI) in firms across nine countries, prior to the boom in generative AI. Based on harmonized analysis applied to official and representative firm-level surveys, it finds that the early use of AI is prevalent in ICT and Professional Services and more widespread across large—and to some extent across young—firms. Different proxies of digital capabilities—notably ICT skills, high-speed digital infrastructure, and digital maturity—exhibit significant complementarities in adoption. Early AI users are on average more productive than other firms. However, this appears to a considerable extent related to the self-selection of firms with higher digital capabilities into AI use. Strengthening digital capabilities of firms and workers can, therefore, be a relevant lever that managers and policy-makers can use to boost both AI diffusion and productivity.
Zitieren
APA
Calvino, F., & Fontanelli, L. (2026). AI, productivity, and digital capabilities: cross-country evidence from early adoption. Industrial and Corporate Change. https://doi.org/10.1093/icc/dtag043
Vancouver
Calvino F, Fontanelli L. AI, productivity, and digital capabilities: cross-country evidence from early adoption. Industrial and Corporate Change. 2026. doi:10.1093/icc/dtag043
BibTeX
@article{Calvino2026,
author = {Calvino, Flavio and Fontanelli, Luca},
title = {AI, productivity, and digital capabilities: cross-country evidence from early adoption},
journal = {Industrial and Corporate Change},
year = {2026},
doi = {10.1093/icc/dtag043}
}
EUVIMED